Canada News Beep | NewsBeep.com
  • News Beep
  • Canada
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Canada News Beep | NewsBeep.com
Canada News Beep | NewsBeep.com
  • News Beep
  • Canada
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Category

Medication

6004 posts
MMedication
FDA grants priority review to 'high-efficacy' oral drug for 2 MS types
Read More

FDA grants priority review to ‘high-efficacy’ oral drug for 2 MS types

  • October 2, 2026
The U.S. Food and Drug Administration (FDA) has agreed to review an application from Roche seeking approval of…
MMedication
$1,900 for pain cream sold for $20: Allstate files triple RICO suits
Read More

$1,900 for pain cream sold for $20: Allstate files triple RICO suits

  • October 2, 2026
Three pharmacies, one alleged playbook – and up to $1,900 for ointment you can buy for $20 What…
MMedication
Karnataka Flags Wide Disparity Between Landing Cost And MRP Of High-Cost Drugs And Medical Consumables, Seeks Central Government Intervention
Read More

Karnataka Flags Wide Disparity Between Landing Cost And MRP Of High-Cost Drugs And Medical Consumables, Seeks Central Government Intervention

  • October 2, 2026
The Karnataka Government during the recent inspection on the Hospitals treating cancer where high cost drugs are used…
MMedication
Maharashtra to start spot tests to find spurious medicines | Pune News
Read More

Maharashtra to start spot tests to find spurious medicines | Pune News

  • October 1, 2026
Maharashtra health minister Prakash Abitkar during his meeting with senior state health department officials in Mumbai on Wednesday…
MMedication
Lilly's oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease
Read More

Lilly’s oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease

  • October 1, 2026
In post-hoc analyses of ATTAIN-1, Foundayo 17.2 mg was associated with a predicted 57% and 18% reduction in…
MMedication
#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy - Endpoints News
Read More

#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy – Endpoints News

  • October 1, 2026
#EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy  Endpoints NewsThe Next Frontier for Obesity Drugs Isn’t…
MMedication
Alka Yagnik meets Alka-Seltzer in Bayer’s new heartburn ad
Read More

Alka Yagnik meets Alka-Seltzer in Bayer’s new heartburn ad

  • October 1, 2026
Bayer’s Consumer Health Division has launched a new digital campaign for Alka-Seltzer featuring playback singer Alka Yagnik. The…
MMedication
Apple App Store
Read More

A popular GLP-1 provider just made its weight loss medications cheaper

  • October 1, 2026
Mochi Health just lowered the cost of its compounded GLP-1 medications while adding a new lab-testing service designed…
MMedication
Peterborough Rexall educates community on medication safety risks - The Peterborough Examiner
Read More

Peterborough Rexall educates community on medication safety risks – The Peterborough Examiner

  • October 1, 2026
Peterborough Rexall educates community on medication safety risks  The Peterborough ExaminerEdmontonians encouraged to safely dispose of unused drugs  CTV NewsIn…
MMedication
Why Some Psychiatrists Prescribe GLP-1s
Read More

Why Some Psychiatrists Prescribe GLP-1s

  • October 1, 2026
Hilary, a 39-year-old in California, has had depression for about as long as she can remember, which means…
MMedication
NVO's Ozempic Outshines LLY's Mounjaro in Lowering Cardiovascular Risk
Read More

NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular Risk

  • October 1, 2026
Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
MMedication
59-year-old dad claims Ozempic left him ‘permanently blind’ within days: What we know about vision loss due to GLP-1 and the lawsuits
Read More

59-year-old dad claims Ozempic left him ‘permanently blind’ within days: What we know about vision loss due to GLP-1 and the lawsuits

  • October 1, 2026
59-year-old dad claims Ozempic left him ‘permanently blind’ within days: What we know about vision loss due to…
Canada News Beep | NewsBeep.com
www.newsbeep.com